InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focus on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for acute SCI; and Therapeutic Trails injection program for the treatment of chronic SCI. The company was founded in 2005 and is based in Cambridge, Massachusetts.
http://www.priceseries.com/trade/NVIV-InVivo-Therapeutics-Holdings-Corp-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2021020320210219.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments